IDIS Tips and News


FORMULATION EFFICACY Descriptor

PDF of this tip

When looking for information on delayed-, time-, sustained-, or extended-release drug products, descriptor "FORMULATION EFFICACY 22" is a helpful descriptor to include in a search statement. Combining this descriptor with a drug term will narrow the search to include articles in which formulations other than the immediate-release or standard product are discussed. One author may refer to it as "sustained-release" whereas another may refer to it as "delayed-release" in the published literature. Descriptor "FORMULATION EFFICACY 22" will ensure that both scenarios are retrieved.
    
More Tips

Login to IDIS


NOTICE:
IDIS database discontinuation December 31, 2014.
Read more.

Your institution might be using IP authentication. If you do not know your Username and Password, try clicking the "Login by IP" button.


   
*Leave Username and Password blank.


 Username:  
 Password:  

       

 


IDIS Logo

  IDIS Drug Database 1966 - November 2014

IDIS Training Tools IDIS Training Tools   |   IDIS on Facebook Facebook   |    IDIS Monthly Update Info Monthly Update Info

Full-text articles/reports from 1988 through the current month are available in IDIS Drug Database.

IDIS is a database of index records to articles about drugs and drug therapy in humans taken from over 200 leading medical and pharmaceutical journals, FDA approval packages, FDA Advisory Committee briefing documents, FDA boxed warnings, AHRQ publications, National Institute for Health and Clinical Excellence (NICE) guidelines and appraisals, clinical practice guidelines and more. The complete article/report is also available online (1988 through the current month). The system is designed to retrieve specific information concerning a drug and/or drug treatment of a disease state. Authoritative publications have been selected to provide broad coverage of both general and specialty areas of pharmacy and medicine.

System Usage: Data retrieved from the database is intended for distribution solely within the subscriber's organization and may not be accessed from more than one computer concurrently without prior written permission from DDIS. The data is not to be transferred, retransmitted or used with other information for the creation of a combined or consolidated database. Under no circumstances may copies of the data be offered for sale or resale.

Division of Drug Information Service
University of Iowa Research Park
2500 Crosspark Road, Room W145
Coralville, IA 52241-4710 USA

Telephone: 319-335-4800
U.S. Toll-free: 800-525-4347
Fax: 319-335-4440
E-mail: idis@uiowa.edu